Cargando…
Critical appraisal of tobacco dependence treatment guidelines
Background Tobacco use is a leading preventable cause of morbidity and mortality globally. Clinical practice guidelines for the treatment of tobacco use dependence are of varied scope and quality, making it challenging for users to select and apply recommendations. Objective The study objective is t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878272/ https://www.ncbi.nlm.nih.gov/pubmed/32897449 http://dx.doi.org/10.1007/s11096-020-01110-4 |
_version_ | 1783650324127416320 |
---|---|
author | El Hajj, Maguy Saffouh Jaam, Myriam Sheikh Ali, Saba Abdal Salam Saleh, Rana Awaisu, Ahmed Paravattil, Bridget Wilby, Kyle John |
author_facet | El Hajj, Maguy Saffouh Jaam, Myriam Sheikh Ali, Saba Abdal Salam Saleh, Rana Awaisu, Ahmed Paravattil, Bridget Wilby, Kyle John |
author_sort | El Hajj, Maguy Saffouh |
collection | PubMed |
description | Background Tobacco use is a leading preventable cause of morbidity and mortality globally. Clinical practice guidelines for the treatment of tobacco use dependence are of varied scope and quality, making it challenging for users to select and apply recommendations. Objective The study objective is to identify and critically appraise the quality of existing clinical practice guidelines for tobacco cessation. Setting The study occurred between collaborative academic institutions located in Qatar and New Zealand. Methods A systematic literature search was performed for the period 2006–2018 through the following databases: PubMed, EMBASE, CINAHL, ISI Web of Science, Scopus, National Guideline Clearing House, Campbell Library, Health System Evidence, Joanna Briggs Institute Evidence-Based Practice Database, Academic Search Complete, ProQuest, PROSPERO, and Google Scholar. Relevant professional societies’ and health agencies’ websites were also searched. Two reviewers independently extracted and assessed guidelines’ quality using Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument. Main outcome measure Standardized domain scores according to the AGREE II instrument. Results 7741 hits were identified. After removing duplicates and screening, 24 guidelines were included. Highest guideline quality was for National Institute for Health and Care Excellence (NICE) guideline with an overall ranking score of 87.56% and least quality was for Japanese Circulation Society Joint Working Group with an overall score of 29.34%. Domain 4 of AGREE II (clarity of presentation) had the highest average quality score (70.95%), while the lowest average quality scores were for Domain 2 (Rigour of Development) (50.21%) and Domain 5 (Applicability) (45.05%). Conclusion Seven guidelines were judged to be of high quality (overall score of ≥ 70%). Future guidelines for tobacco dependence treatment should use rigorous methods of development and provide applicable recommendations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11096-020-01110-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7878272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-78782722021-02-22 Critical appraisal of tobacco dependence treatment guidelines El Hajj, Maguy Saffouh Jaam, Myriam Sheikh Ali, Saba Abdal Salam Saleh, Rana Awaisu, Ahmed Paravattil, Bridget Wilby, Kyle John Int J Clin Pharm Research Article Background Tobacco use is a leading preventable cause of morbidity and mortality globally. Clinical practice guidelines for the treatment of tobacco use dependence are of varied scope and quality, making it challenging for users to select and apply recommendations. Objective The study objective is to identify and critically appraise the quality of existing clinical practice guidelines for tobacco cessation. Setting The study occurred between collaborative academic institutions located in Qatar and New Zealand. Methods A systematic literature search was performed for the period 2006–2018 through the following databases: PubMed, EMBASE, CINAHL, ISI Web of Science, Scopus, National Guideline Clearing House, Campbell Library, Health System Evidence, Joanna Briggs Institute Evidence-Based Practice Database, Academic Search Complete, ProQuest, PROSPERO, and Google Scholar. Relevant professional societies’ and health agencies’ websites were also searched. Two reviewers independently extracted and assessed guidelines’ quality using Appraisal of Guidelines, Research and Evaluation II (AGREE II) instrument. Main outcome measure Standardized domain scores according to the AGREE II instrument. Results 7741 hits were identified. After removing duplicates and screening, 24 guidelines were included. Highest guideline quality was for National Institute for Health and Care Excellence (NICE) guideline with an overall ranking score of 87.56% and least quality was for Japanese Circulation Society Joint Working Group with an overall score of 29.34%. Domain 4 of AGREE II (clarity of presentation) had the highest average quality score (70.95%), while the lowest average quality scores were for Domain 2 (Rigour of Development) (50.21%) and Domain 5 (Applicability) (45.05%). Conclusion Seven guidelines were judged to be of high quality (overall score of ≥ 70%). Future guidelines for tobacco dependence treatment should use rigorous methods of development and provide applicable recommendations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11096-020-01110-4) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-09-08 2021 /pmc/articles/PMC7878272/ /pubmed/32897449 http://dx.doi.org/10.1007/s11096-020-01110-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article El Hajj, Maguy Saffouh Jaam, Myriam Sheikh Ali, Saba Abdal Salam Saleh, Rana Awaisu, Ahmed Paravattil, Bridget Wilby, Kyle John Critical appraisal of tobacco dependence treatment guidelines |
title | Critical appraisal of tobacco dependence treatment guidelines |
title_full | Critical appraisal of tobacco dependence treatment guidelines |
title_fullStr | Critical appraisal of tobacco dependence treatment guidelines |
title_full_unstemmed | Critical appraisal of tobacco dependence treatment guidelines |
title_short | Critical appraisal of tobacco dependence treatment guidelines |
title_sort | critical appraisal of tobacco dependence treatment guidelines |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878272/ https://www.ncbi.nlm.nih.gov/pubmed/32897449 http://dx.doi.org/10.1007/s11096-020-01110-4 |
work_keys_str_mv | AT elhajjmaguysaffouh criticalappraisaloftobaccodependencetreatmentguidelines AT jaammyriam criticalappraisaloftobaccodependencetreatmentguidelines AT sheikhalisabaabdalsalam criticalappraisaloftobaccodependencetreatmentguidelines AT salehrana criticalappraisaloftobaccodependencetreatmentguidelines AT awaisuahmed criticalappraisaloftobaccodependencetreatmentguidelines AT paravattilbridget criticalappraisaloftobaccodependencetreatmentguidelines AT wilbykylejohn criticalappraisaloftobaccodependencetreatmentguidelines |